Drug Database · Clinicians

Dexamethasone + Levofloxacin

Brands (1) DucressaShow all

Anti-infective-anti-inflammatory combination PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in… US FDA label

  • Use: Levofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1 , 12.4 ). US FDA label

    Kidney dosing: Levofloxacin (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Usual dose: 250, 500 or 750 mg every 24 hours by infection (label).
    CrCl 30–59 mL/min
    CrCl ≥50: usual dose. CrCl 20–49: 750 mg every 48 hours; or 500 mg once, then 250 mg every 24 hours; 250 mg regimen unchanged (label).
    CrCl 15–29 mL/min
    CrCl 20–49: as above. CrCl 10–19: 750 mg once, then 500 mg every 48 hours; or 500 mg once, then 250 mg every 48 hours; 250 mg regimen becomes every 48 hours (no change for uncomplicated UTI) (label).
    CrCl <15 mL/min (not on dialysis)
    CrCl 10–19: as above. Below 10 not on dialysis: not addressed in label; specialist input.
    Hemodialysis (intermittent)
    750 mg once, then 500 mg every 48 hours; or 500 mg once, then 250 mg every 48 hours. No supplemental dose after dialysis. 250 mg regimen: no information (label).
    Peritoneal dialysis
    CAPD: same as hemodialysis; no supplemental dose (label). For PD-associated peritonitis (ISPD 2022, systemic): oral 250 mg daily or 500 mg every 48 hours (Table 6).
    CRRT
    Not in label. Limited data: about 250 mg every 24 hours at low effluent; poor target attainment on CVVHD, so avoid as gram-negative monotherapy; specialist input (Li 2020).
    • Dialyzable? No: not efficiently removed by hemodialysis or peritoneal dialysis (label).
    • Monitoring Tendon rupture, QT prolongation, dysglycemia, central nervous system effects; risk higher in older adults and kidney impairment.

    From the Levofloxacin monograph (renalcarematters.com, reviewed).

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per ml ophthalmic solution: 5 mg/1 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Dexamethasone + Levofloxacin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Dexamethasone + Levofloxacin
Package insert
DucressaLevofloxacin (as hemihydrate) + Dexamethasone (as sodium phosphate)
5 mg / 1 mg per mL Ophthalmic Solution (Eye Drops)5 mL white LDPE bottle with white LDPE dropper tip and white HDPE screw cap (Box of 1's)
Rx
Tubilux Pharma S.p.A.Italy
Importer: Santen Philippines, Inc.
DR-XY48389
Oct 3, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .